CSL Limited

$111.50
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.20 (+1.09%) Today
$0.00 (0.00%) As of 4:23 PM EST after-hours

Why Robinhood?

You can buy or sell CSL Limited and other stocks, options, and ETFs commission-free!

About CSLLY

Csl Ltd SPONSORED ADR (Australia), also called CSL Limited, is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the CSL Behring and Seqirus segments. The CSL Behring segment provides plasma therapies and conducts early stage research on plasma and non plasma therapies. The Seqirus segment involves in the production of non-plasma biotherapeutic products and develops influenza related products. The company was founded on November 2, 1961 and is headquartered in Parkville, Australia. CSLLY is listed on the Pink Current market tier. OTC market data is provided by OTC Markets Group, Inc (otcmarkets.com). The listed name for CSLLY is Csl Ltd SPONSORED ADR (Australia).

CEO
Paul Roger Perreault
Employees
27,000
Headquarters
Parkville, Victoria (VIC)
Founded
1961
Market Cap
101.46B
Price-Earnings Ratio
48.42
Dividend Yield
0.80
Average Volume
40.60K
High Today
$111.52
Low Today
$110.50
Open Price
$110.74
Volume
31.06K
52 Week High
$117.98
52 Week Low
$75.19

Collections

You May Also Like